BioLineRx's BL-8040 for stem cell mobilization receives Orphan Drug designation

BioLineRx's BL-8040 for stem cell mobilization receives Orphan Drug designation BioLineRx has received notice from the FDA confirming an Orphan Drug Designation of BL-8040 as a treatment for stem cell mobilization, in addition to the Orphan Drug Designation previously granted to BL-8040 as a treatment for Acute Myeloid Leukemia.

http://ift.tt/1mKyAti